PepTivator® AdV5 Hexon

The PepTivator® AdV5 Hexon is a peptide pool that consists mainly of 15-mer peptides with 11–amino acid overlap, covering the complete sequence of the hexon protein of human adenovirus 5 (AdV-5) (Swiss-Prot Acc. no. P04133).

PepTivator Peptide Pools have been especially developed for the efficient in vitro stimulation of antigen–specific CD4+ and CD8+ T cells, as peptides of 15 aa length with 11-aa overlap represent an optimized solution for stimulating both CD4+ and CD8+ T cells in various applications.1

Q

... read more
Choose your product:

Related products for PepTivator® AdV5 Hexon

Specifications for PepTivator® AdV5 Hexon
Overview

The PepTivator® AdV5 Hexon is a peptide pool that consists mainly of 15-mer peptides with 11–amino acid overlap, covering the complete sequence of the hexon protein of human adenovirus 5 (AdV-5) (Swiss-Prot Acc. no. P04133).

PepTivator Peptide Pools have been especially developed for the efficient in vitro stimulation of antigen–specific CD4+ and CD8+ T cells, as peptides of 15 aa length with 11-aa overlap represent an optimized solution for stimulating both CD4+ and CD8+ T cells in various applications.1

Quantitative, phenotypical, or functional analysis of AdV5 hexon–specific T cell immunity can provide important information on the natural course of immune responses in healthy or immunocompromised individuals.

Detailed product information
Background information

Adenoviruses (AdV) are non-enveloped, ubiquitous, lytic double-stranded DNA viruses. Up to now, 52 different human serotypes (1–52), divided into six species (A-F) are described. The hexon protein is one of the structural proteins in the viral coat and is synthesized during late infection. It is the immunodominant T cell target among capsid proteins and contains multiple epitopes conserved among serotypes.

Downstream applications

The in vitro stimulation of AdV5 hexon–specific CD4+ and CD8+ T cells with PepTivator AdV5 Hexon causes secretion of effector cytokines and upregulation of activation markers, which then allow the detection and isolation of AdV5 hexon–specific T cells 2-4:

  • Detection and analysis of AdV5 hexon–specific CD4+ and CD8+ effector/memory T cells in PBMCs by MACS® Cytokine Secretion Assays, intracellular cytokine staining, or other technologies.
  • Isolation of viable AdV5 hexon–specific CD4+ T cells with the CD154 MicroBead Kit, or of CD4+ and CD8+ T cells using the CD137 MicroBead Kit or MACS Cytokine Secretion Assay – Cell Enrichment and Detection Kits. Subsequently, cells can be expanded for generation of T cell lines.
  • Generation of AdV5 hexon–specific CD4+ and CD8+ effector/memory T cells from naive T cell populations for research on immunotherapy and vaccination.
  • Pulsing of antigen-presenting cells for research on dendritic cell vaccination.
Product data and images for PepTivator® AdV5 Hexon
Figure 1

Production of IFN-γ by human CD4+ or CD8+ T cells after stimulation with different antigens using PepTivator Peptide Pools. Data from two different donors are shown (triplicates).

Citations for PepTivator® AdV5 Hexon
Publications
  1. Kiecker, F. et al. (2004) Analysis of antigen-specific T-cell responses with synthetic peptides--what kind of peptide for which purpose? Hum Immunol 65: 523-536
  2. Guérin-El Khourouj, V. et al. (2011) Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 17 (4): 476-485
  3. Draper, S. J. et al. (2010) Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines. J Immunol 185: 7583-7595
  4. Aïssi-Rothé, L. et al. (2010) Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy. J Immunother 33 (4): 414-424

You have previously chosen International as your location.
What do you want to do?